S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
66,000% upside on tiny biotech? (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
66,000% upside on tiny biotech? (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
66,000% upside on tiny biotech? (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Baby eels remain one of America's most valuable fish after strong year in Maine
China's 1st domestically made passenger plane completes maiden commercial flight
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
'Succession' fans brace for series finale of Emmy-winning hit drama
66,000% upside on tiny biotech? (Ad)
Voters in Turkey choose between Erdogan and Kilicdaroglu in presidential runoff
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
NASDAQ:SGEN

Seagen (SGEN) Stock Forecast, Price & News

$193.49
-0.95 (-0.49%)
(As of 05/26/2023 ET)
Compare
Today's Range
$192.50
$195.74
50-Day Range
$187.64
$206.25
52-Week Range
$116.08
$207.16
Volume
1.26 million shs
Average Volume
1.70 million shs
Market Capitalization
$36.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$190.47

Seagen MarketRank™ Forecast

Analyst Rating
Hold
2.35 Rating Score
Upside/​Downside
1.6% Downside
$190.47 Price Target
Short Interest
Healthy
3.41% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-2.11
Upright™ Environmental Score
News Sentiment
0.92mentions of Seagen in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$30.56 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.96) to ($0.98) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Medical Sector

653rd out of 1,012 stocks

Biological Products, Except Diagnostic Industry

100th out of 169 stocks


SGEN stock logo

About Seagen (NASDAQ:SGEN) Stock

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also engages in the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Stock News Headlines

Is Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny? (SGEN)
Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal.
StockNews.com Begins Coverage on Seagen (NASDAQ:SGEN)
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Seagen Inc. (NASDAQ:SGEN) EVP Sells $66,261.14 in Stock
Analysts Set Seagen Inc. (NASDAQ:SGEN) PT at $194.73
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Seagen (SGEN) Rose on Acquisition Announcement
Seagen (NASDAQ:SGEN) Shares Gap Down on Insider Selling
Nasdaq 100 Movers: SGEN, AMD
Seagen Inc.
Seagen (SGEN) Receives a Hold from Berenberg Bank
See More Headlines
Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

SGEN Company Calendar

Last Earnings
4/27/2023
Today
5/28/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:SGEN
CUSIP
81257810
Employees
3,256
Year Founded
1998

Price Target and Rating

Average Stock Price Forecast
$190.47
High Stock Price Forecast
$229.00
Low Stock Price Forecast
$129.00
Forecasted Upside/Downside
-1.6%
Consensus Rating
Hold
Rating Score (0-4)
2.35
Research Coverage
17 Analysts

Profitability

Net Income
$-610,310,000.00
Pretax Margin
-31.00%

Debt

Sales & Book Value

Annual Sales
$2.06 billion
Book Value
$14.52 per share

Miscellaneous

Free Float
138,940,000
Market Cap
$36.28 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • David R. Epstein
    Chief Executive Officer & Director
  • Todd E. SimpsonTodd E. Simpson
    Chief Financial Officer
  • Vaughn B. HimesVaughn B. Himes
    Chief Technical Officer
  • Roger D. DanseyRoger D. Dansey
    Chief Medical Officer & President-Research
  • Karin A. Tollefson
    Senior VP & Head-Global Medical Affairs













SGEN Stock - Frequently Asked Questions

Should I buy or sell Seagen stock right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Seagen in the last year. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGEN, but not buy additional shares or sell existing shares.
View SGEN analyst ratings
or view top-rated stocks.

What is Seagen's stock price forecast for 2023?

17 Wall Street research analysts have issued 1 year target prices for Seagen's shares. Their SGEN share price forecasts range from $129.00 to $229.00. On average, they expect the company's stock price to reach $190.47 in the next twelve months. This suggests that the stock has a possible downside of 1.6%.
View analysts price targets for SGEN
or view top-rated stocks among Wall Street analysts.

How have SGEN shares performed in 2023?

Seagen's stock was trading at $128.51 at the start of the year. Since then, SGEN shares have increased by 50.6% and is now trading at $193.49.
View the best growth stocks for 2023 here
.

When is Seagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our SGEN earnings forecast
.

How were Seagen's earnings last quarter?

Seagen Inc. (NASDAQ:SGEN) posted its earnings results on Thursday, April, 27th. The biotechnology company reported ($0.93) earnings per share for the quarter, missing the consensus estimate of ($0.82) by $0.11. The biotechnology company earned $519.70 million during the quarter, compared to analyst estimates of $516.28 million. Seagen had a negative net margin of 31.55% and a negative trailing twelve-month return on equity of 23.00%. The firm's quarterly revenue was up 21.9% compared to the same quarter last year. During the same period last year, the company posted ($0.74) earnings per share.

What is Clay B. Siegall's approval rating as Seagen's CEO?

107 employees have rated Seagen Chief Executive Officer Clay B. Siegall on Glassdoor.com. Clay B. Siegall has an approval rating of 99% among the company's employees. This puts Clay B. Siegall in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Seagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Seagen investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Salesforce (CRM), QUALCOMM (QCOM), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Alibaba Group (BABA).

What is Seagen's stock symbol?

Seagen trades on the NASDAQ under the ticker symbol "SGEN."

Who are Seagen's major shareholders?

Seagen's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baker BROS. Advisors LP (25.02%), BlackRock Inc. (5.97%), Wellington Management Group LLP (3.64%), State Street Corp (1.79%), Geode Capital Management LLC (1.05%) and Avoro Capital Advisors LLC (0.96%). Insiders that own company stock include Bros Advisors Lp Baker, Charles R Romp, Charles R Romp, Clay B Siegall, Clay B Siegall, Daniel G Welch, Daniel G Welch, David W Gryska, David W Gryska, Jean I Liu, Jean I Liu, Morgan E Obrien, Roger D Dansey, Roger D Dansey, Todd E Simpson, Todd E Simpson, Vaughn B Himes and Vaughn B Himes.
View institutional ownership trends
.

How do I buy shares of Seagen?

Shares of SGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Seagen's stock price today?

One share of SGEN stock can currently be purchased for approximately $193.49.

How much money does Seagen make?

Seagen (NASDAQ:SGEN) has a market capitalization of $36.28 billion and generates $2.06 billion in revenue each year. The biotechnology company earns $-610,310,000.00 in net income (profit) each year or ($3.49) on an earnings per share basis.

How many employees does Seagen have?

The company employs 3,256 workers across the globe.

Does Seagen have any subsidiaries?
The following companies are subsidiares of Seagen: Cascadian Therapeutics.
Read More
How can I contact Seagen?

Seagen's mailing address is 21823 30TH DRIVE SE SUITE, BOTHELL WA, 98021. The official website for the company is www.seattlegenetics.com. The biotechnology company can be reached via phone at (425) 527-4000, via email at investors@seagen.com, or via fax at 425-527-4001.

This page (NASDAQ:SGEN) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -